Live Breaking News & Updates on Pashtoon murtaza kasi

Dr Kasi on the Potential Implications of ctDNA presence in Colorectal Cancer

Dr Kasi on the Potential Implications of ctDNA presence in Colorectal Cancer
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Pashtoon-murtaza-kasi , Weill-cornell-medicine , Newyork-presbyterian-hospital ,

Dr Kasi on the Use of ctDNA to Help Inform Adjuvant Treatment Decisions in CRC

Pashtoon Murtaza Kasi, MD, M.S on the potential of ctDNA to guide further adjuvant treatment decisions in CRC and other tumor types.

Pashtoon-murtaza-kasi , Weill-cornell-medicine , Newyork-presbyterian-hospital ,

Uncertainty Surrounds Sensitivity of ctDNA in CRC

CtDNA is a useful prognostic tool in CRC, but it's unclear whether it can guide the use of adjuvant chemotherapy.

Boston , Massachusetts , United-states , Memorial-sloan-kettering-cancer-center , New-york , Australia , David-ellison , Aparna-raj-parikh , Hiroki-yukami , Eujung-kim , Harvard-medical-school , Peter-maccallum-cancer-centre

Neoadjuvant Botensilimab/Balstilimab Produces Early Responses in CRC

Patients with resectable mismatch repair-proficient and -deficient colorectal cancer had robust responses to neoadjuvant botensilimab/balstilimab.

Newyork-presbyterian-hospital , New-york , United-states , Pashtoon-murtaza-kasi , Weill-cornell-medicine , News , Gastric-cancer , Colorectal-cancer , Asco-gi , Conference , Botensilimab

Cancer in Bloodstream May Predict CRC Outcomes

Circulating tumor DNA-based minimal residual disease lent insight into which patients with stage 2/3 colorectal cancer may be at higher risk for recurrence and which could benefit from postsurgical chemotherapy.

United-states , New-york , Pashtoon-murtaza-kasi , Weill-cornell-medicine , New-york-presbyterian-hospital , News , Gastric-cancer , Colorectal-cancer , Conference , Asco-gi ,